期刊簡介預(yù)計審稿時間： 較慢,6-12周

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology

Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug

The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

《藥物發(fā)現(xiàn)專家意見》（ISSN 1746-0441 [印刷版]，1746-045X [電子版]）是一本 MEDLINE 索引、同行評審的國際期刊，發(fā)表有關(guān)藥物發(fā)現(xiàn)過程中涉及的新技術(shù)的評論文章，從而帶來新的線索并降低流失率。每篇文章都包含作者自己對未來發(fā)展范圍的專家意見。

編輯歡迎：

評論涵蓋化學(xué)信息學(xué)；生物信息學(xué)；檢測開發(fā)；新型篩選技術(shù)；體外/體內(nèi)模型；基于結(jié)構(gòu)的藥物設(shè)計；系統(tǒng)生物學(xué)

藥物案例歷史，研究特定藥物的臨床前和臨床開發(fā)所涉及的步驟

讀者包括醫(yī)療保健和制藥行業(yè)的科學(xué)家和管理人員、學(xué)術(shù)制藥科學(xué)家和其他密切相關(guān)的專業(yè)人士，他們希望通過臨床前水平的優(yōu)化來提高其候選藥物的成功率。

《Expert Opinion On Drug Discovery》(關(guān)于藥物發(fā)現(xiàn)的專家意見)編輯部通訊方式為INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。